New York, USA, July 31, 2024 (GLOBE NEWSWIRE) -- Global Intracranial Stents Market to Showcase Growth at a CAGR of ~7% by 2030 | DelveInsight
The surge in demand for intracranial stents is predominantly driven by the growing occurrence of neurological conditions like intracranial stenosis and brain aneurysm. Furthermore, the rising prevalence of ischemic stroke and transient ischemic attack (TIA), coupled with advancements in technology fostering product innovation and introductions, are pivotal factors fueling the expansion of the intracranial stents market from 2024 to 2030.
DelveInsight’s Intracranial Stents Market Insights report provides the current and forecast market analysis, individual leading intracranial stents companies’ market shares, challenges, intracranial stents market drivers, barriers, trends, and key market intracranial stents companies in the market.
Key Takeaways from the Intracranial Stents Market Report
- As per DelveInsight estimates, North America is anticipated to dominate the global intracranial stents market during the forecast period.
- In the product segment of the Intracranial Stents market, the self-expanding stents category had a significant revenue share in the intracranial stents market in 2023.
- Notable intracranial stents companies such as Stryker, Boston Scientific Corporation, Terumo Corporation, Medtronic, Cook, MicroPort Scientific Corporation, DePuy Synthes, Acandis GmBH, Balt Group, MicroVention Inc., Sino Medical Sciences Technology Inc., Johnson & Johnson, Inc., Phenox GmbH, INVAMED, InspireMD Inc., and several others, are currently operating in the intracranial stents market.
- In September 2022, Wallaby/phenox launched their novel pEGASUS HPC stent at the ESMINT 2022 congress in Nice, France.
- In June 2022, Medtronic launched its CE-marked fourth-generation flow diverter, to treat brain aneurysms.
- In August 2021, Fluid Biotech received USD 5.8 million funding, for the development of its innovative stent for the treatment of brain aneurysms.
To read more about the latest highlights related to the intracranial stents market, get a snapshot of the key highlights entailed in the Global Intracranial Stents Market Report
Intracranial Stents Overview
Intracranial stents have emerged as a critical tool in the management of various neurological conditions, particularly in the realm of cerebrovascular diseases. These tiny mesh-like devices are delicately placed within the blood vessels of the brain to provide structural support, reinforce vessel walls, and facilitate blood flow regulation. Primarily used in the treatment of conditions such as intracranial aneurysms, stenosis, and acute ischemic stroke, these stents offer a minimally invasive alternative to traditional surgical interventions. By deploying advanced materials and design technologies, modern intracranial stents aim to strike a delicate balance between optimal vessel patency and reduced risk of complications, offering patients a promising avenue for improved outcomes and enhanced quality of life.
The evolution of intracranial stents reflects a remarkable convergence of medical innovation and precision engineering. As researchers delve deeper into understanding the intricate dynamics of cerebral vasculature, the design and composition of these stents continue to evolve, emphasizing biocompatibility, flexibility, and navigational ease. With advancements such as self-expanding stents and drug-eluting coatings, the field is witnessing a paradigm shift towards personalized, patient-centric interventions. Moreover, ongoing research endeavors are exploring the potential of intracranial stents beyond their traditional applications, with investigations into their role in neurovascular reconstruction and targeted drug delivery. As these technologies mature and integrate seamlessly into clinical practice, intracranial stents are poised to redefine the landscape of cerebrovascular medicine, offering new avenues for treatment and fostering hope for patients with complex neurological conditions.
Intracranial Stents Market Insights
In 2023, North America dominated the intracranial stents market, mainly because of its substantial patient base dealing with ischemic stroke and transient ischemic attack (TIA). Factors such as a growing elderly population, the presence of major industry players, advanced healthcare infrastructure, and a robust environment for product development and launches contribute significantly to this dominance. According to the Centers for Disease Control and Prevention (CDC), approximately 795,000 individuals in the United States experience a stroke annually, with 87% of these being ischemic strokes.
Moreover, the US Census Bureau's 2021 data indicates that over 54 million adults aged 65 and above reside in the United States, a number projected to reach 85.7 million by 2050, constituting around 20% of the total population. Given that individuals over 50, particularly the elderly, are more susceptible to ischemic stroke and TIA due to natural arterial narrowing and atherosclerosis, the prevalence of these conditions, along with the aging population, serves as primary drivers for the intracranial stents market in the United States, thereby fueling its growth in North America.
To know more about why North America is leading the market growth in the intracranial stents market, get a snapshot of the Intracranial Stents Market Outlook
Intracranial Stents Market Dynamics
The intracranial stents market dynamics are shaped by a convergence of technological advancements, rising incidences of cerebrovascular diseases, and an increasing emphasis on minimally invasive treatment options. As medical technology continues to advance, intracranial stents have emerged as a promising solution for the treatment of various cerebrovascular conditions, including aneurysms and ischemic strokes. This has led to a surge in demand for these devices, driving intracranial stents market growth.
Moreover, the aging population worldwide has contributed to the growing prevalence of cerebrovascular diseases, such as strokes and aneurysms. This demographic shift has created a substantial patient pool in need of treatment, further fueling the demand for intracranial stents. Additionally, the preference for minimally invasive procedures among patients and healthcare providers has bolstered the adoption of intracranial stents, as they offer reduced recovery times and fewer complications compared to traditional surgical interventions.
Furthermore, the intracranial stents market is characterized by intense competition among key players, leading to continuous innovation and product development. Manufacturers are focusing on enhancing the efficacy and safety profiles of their products, as well as expanding their product portfolios to cater to evolving patient needs. Collaborations between industry players and research institutions are also driving advancements in intracranial stent technology, further propelling intracranial stents market growth. Overall, with the convergence of these factors, the intracranial stents market is poised for continued expansion in the coming years.
Get a sneak peek at the intracranial stents market dynamics @ Intracranial Stents Market Dynamics Analysis
| Report Metrics | Details |
| Coverage | Global |
| Study Period | 2021–2030 |
| Intracranial Stents Market CAGR | ~7% |
| Key Intracranial Stents Companies | Stryker, Boston Scientific Corporation, Terumo Corporation, Medtronic, Cook, MicroPort Scientific Corporation, DePuy Synthes, Acandis GmBH, Balt Group, MicroVention Inc., Sino Medical Sciences Technology Inc., Johnson & Johnson, Inc., Phenox GmbH, INVAMED, InspireMD Inc., among others |
Intracranial Stents Market Assessment
- Intracranial Stents Market Segmentation
- Intracranial Stents Market Segmentation By Product: Self-Expanding Stents, Balloon Expanding Stents, and Others
- Intracranial Stents Market Segmentation By Application: Intracranial Stenosis and Brain Aneurysm
- Intracranial Stents Market Segmentation By End User: Hospitals, Ambulatory Surgical Centers, and Others
- Intracranial Stents Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the intracranial stents market are set to emerge as the trendsetter explore @ Intracranial Stents Companies
Table of Contents
| 1 | Intracranial Stents Market Report Introduction |
| 2 | Intracranial Stents Market Executive Summary |
| 3 | Competitive Landscape |
| 4 | Regulatory Analysis |
| 5 | Intracranial Stents Market Key Factors Analysis |
| 6 | Intracranial Stents Market Porter’s Five Forces Analysis |
| 7 | Intracranial Stents Market Layout |
| 8 | Intracranial Stents Market Company and Product Profiles |
| 9 | KOL Views |
| 10 | Project Approach |
| 11 | About DelveInsight |
| 12 | Disclaimer & Contact Us |
Interested in knowing the intracranial stents market by 2030? Click to get a snapshot of the Intracranial Stents Market Trends
Related Reports
Ischemic Stroke Pipeline Insight – 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key Ischemic Stroke companies, including Athersys, Inc., Tarveda Therapeutics, Lumosa Therapeutics, NC Medial Research Inc, Acticor Biotech, Meridigen Biotech Co., Prolong Pharmaceuticals, Nanjing Yoko Biomedical Co., Ltd., TrueBinding, Inc., GNT Pharma, Roche, DiaMedica Therapeutics Inc, aptaTargets, Bristol-Myers Squibb, NuvOX Pharma, Simcere Pharmaceutical Co., Ltd., Genentech, Inc., NoNO Inc., Pharming Technologies B.V., Biogen, Avilex Pharma, SanBio, ZZ Biotech, Revalesio, Stemedica Cell Technologies, StemCyte, Ninnion, Algernon Pharmaceuticals, Primary Peptides, TMS, Tasly Pharmaceutical, Pharmazz, among others.
Acute Ischemic Stroke Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key acute ischemic stroke companies, including Acticor Biotech, DiaMedica Therapeutics, Lumosa Therapeutics, Bristol Myers Squibb, Janssen Pharmaceutical, Genentech, Inc., Athersy, Healios K.K., NoNO Inc., Bayer, ZZ Biotech, Biogen Inc., Revalesio Corporation, AbbVie, TrueBinding, Inc, Silver Creek Pharmaceuticals, among others.
Acute Ischemic Stroke Pipeline
Acute Ischemic Stroke Pipeline Insight – 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key acute ischemic stroke companies, including Genentech, Acticor Biotech, DiaMedica Therapeutics, and NoNO, among others.
Brain Aneurysm Stents Market Insights, Competitive Landscape, and Market Forecast – 2030 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key brain aneurysm stents companies, including Phenox GmbH, Peter LAZIC GmbH, adeor medical AG., Boston Scientific Corporation, among others.
Intracranial Aneurysms Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key intracranial aneurysms companies, including Medtronic, MicroPort Scientific Corporation., B. Braun Melsungen AG, Stryker, Johnson & Johnson Services, Inc., Terumo Corporation, Penumbra, Inc., Balt, Wallaby Medical., Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., Mizuho Medical Co.Ltd., Lepu Medical Technology(Beijing)Co., Ltd., Phenox GmbH, Peter LAZIC GmbH, adeor medical AG., Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., KANEKA CORPORATION, among others.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
